Apollo Hospitals Enterprise Management

Management criteria checks 4/4

Apollo Hospitals Enterprise's CEO is Suneeta Reddy, appointed in Jul 2014, has a tenure of 9.75 years. total yearly compensation is ₹67.20M, comprised of 63.2% salary and 36.8% bonuses, including company stock and options. directly owns 3.36% of the company’s shares, worth ₹30.86B. The average tenure of the management team and the board of directors is 13 years and 9.9 years respectively.

Key information

Suneeta Reddy

Chief executive officer

₹67.2m

Total compensation

CEO salary percentage	63.2%
CEO tenure	9.8yrs
CEO ownership	3.4%
Management average tenure	13yrs
Board average tenure	9.9yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Suneeta Reddy's remuneration changed compared to Apollo Hospitals Enterprise's earnings?
Date	Total Compensation	Salary	Company Earnings
Dec 31 2023	n/a	n/a	₹8b
Sep 30 2023	n/a	n/a	₹7b
Jun 30 2023	n/a	n/a	₹7b
Mar 31 2023	₹67m	₹42m	₹8b
Dec 31 2022	n/a	n/a	₹8b
Sep 30 2022	n/a	n/a	₹8b
Jun 30 2022	n/a	n/a	₹9b
Mar 31 2022	₹60m	₹38m	₹11b
Dec 31 2021	n/a	n/a	₹11b
Sep 30 2021	n/a	n/a	₹10b
Jun 30 2021	n/a	n/a	₹8b
Mar 31 2021	₹29m	₹29m	₹2b
Dec 31 2020	n/a	n/a	₹2b
Sep 30 2020	n/a	n/a	₹2b
Jun 30 2020	n/a	n/a	₹2b
Mar 31 2020	₹47m	₹36m	₹5b
Dec 31 2019	n/a	n/a	₹3b
Sep 30 2019	n/a	n/a	₹3b
Jun 30 2019	n/a	n/a	₹3b
Mar 31 2019	₹40m	₹29m	₹2b
Mar 31 2018	₹38m	₹29m	₹1b

Compensation vs Market: Suneeta's total compensation ($USD806.60K) is about average for companies of similar size in the Indian market ($USD942.67K).

Compensation vs Earnings: Suneeta's compensation has been consistent with company performance over the past year.

CEO

Suneeta Reddy (64 yo)

9.8yrs

Tenure

₹67,200,000

Compensation

Mrs. Suneeta Reddy has been Managing Director of Apollo Hospitals Enterprise Ltd. since July 2, 2014. Mrs. Reddy has been an Independent Director at Apeejay Surrendra Park Hotels Limited since December 23,...

Leadership Team

Name	Position	Tenure	Compensation	Ownership
Prathap Reddy	Founder & Executive Chairman	44.3yrs	₹181.13m	0.17% ₹ 1.6b
Suneeta Reddy	MD & Executive Director	9.8yrs	₹67.20m	3.36% ₹ 30.9b
Sangita Reddy	Joint MD & Executive Director	9.8yrs	₹65.41m	1.69% ₹ 15.5b
P. Reddy	Executive Vice-Chairperson	35.2yrs	₹67.46m	0.73% ₹ 6.7b
Shobana Kamineni	Executive Vice Chairperson	14.2yrs	₹63.40m	1.56% ₹ 14.3b
Krishnan Akhileswaran	Chief Financial Officer	no data	₹41.00m	no data
S. Krishnan	Senior VP of Finance	14yrs	₹12.00m	no data
Krishnaswami Padmanabhan	Group President	no data	₹10.11m	no data
Sindoori Reddy	Vice President of Operations	13.5yrs	no data	0.22% ₹ 2.0b
G. Dasaratha Reddy	Senior General Manager of Finance & Accounts	no data	no data	no data
Binod Samal	Chief Technology Officer	13yrs	₹4.17m	no data
Arvind Sivaramakrishnan	Chief Information Officer	13.1yrs	no data	no data

13.0yrs

Average Tenure

62yo

Average Age

Experienced Management: 508869's management team is seasoned and experienced (13 years average tenure).

Board Members

Name	Position	Tenure	Compensation	Ownership
Prathap Reddy	Founder & Executive Chairman	44.3yrs	₹181.13m	0.17% ₹ 1.6b
Suneeta Reddy	MD & Executive Director	23.9yrs	₹67.20m	3.36% ₹ 30.9b
Sangita Reddy	Joint MD & Executive Director	23.8yrs	₹65.41m	1.69% ₹ 15.5b
P. Reddy	Executive Vice-Chairperson	35.2yrs	₹67.46m	0.73% ₹ 6.7b
Shobana Kamineni	Executive Vice Chairperson	14.2yrs	₹63.40m	1.56% ₹ 14.3b
Rama Bijapurkar	Non-Executive Independent Director	2.4yrs	₹3.10m	no data
Som Mittal	Non-Executive Independent Director	2.8yrs	₹3.60m	0.00010% ₹ 917.9k
Mandavilli Bhaskara Rao	Lead Independent Director	5.2yrs	₹4.70m	0.00056% ₹ 5.1m
Pudugramam Doraiswamy	Non-Executive Independent Director	5.6yrs	₹4.30m	no data
Velagapudi Dutt	Independent Director	5.2yrs	₹3.70m	0.00070% ₹ 6.4m

9.9yrs

Average Tenure

65yo

Average Age

Experienced Board: 508869's board of directors are considered experienced (9.9 years average tenure).

Apollo Hospitals Enterprise Management

Management criteria checks 4/4

Key information

Recent management updates

Apollo Hospitals Enterprise Limited Announces Term Completion of Vinayak Chatterjee as Independent Director and Reconstitution of Committees

Apollo Hospitals Announces Management Changes

Apollo Hospitals Enterprise Limited Appoints Madhu Sasidhar as Chief Strategy Officer of the Company W.E.F. 1St October, 2023

Apollo Hospitals Enterprise Limited, Annual General Meeting, Aug 28, 2023

MD & Executive Director recently bought ₹9.5m worth of stock

MD & Executive Director recently sold ₹3.6b worth of stock

Recent updates

Apollo Hospitals Enterprise Limited Announces Term Completion of Vinayak Chatterjee as Independent Director and Reconstitution of Committees

Apollo Hospitals Announces Management Changes

Upcoming dividend of ₹6.00 per share at 0.3% yield

Price target increased by 9.7% to ₹6,714

Dividend of ₹6.00 announced

Third quarter 2024 earnings: EPS misses analyst expectations

Apollo Hospitals Enterprise Limited Declares Interim Dividend for the Financial Year Ending 31st March 2024, Payable on or Before 6th March 2024

Apollo Hospitals Enterprise Limited to Report Q3, 2024 Results on Feb 08, 2024

Second quarter 2024 earnings: EPS misses analyst expectations

Apollo Hospitals Enterprise Limited to Report Q2, 2024 Results on Nov 09, 2023

Apollo Hospitals Enterprise Limited Appoints Madhu Sasidhar as Chief Strategy Officer of the Company W.E.F. 1St October, 2023

New minor risk - Financial position

Upcoming dividend of ₹9.00 per share at 0.4% yield

Full year 2023 earnings: EPS misses analyst expectations

Apollo Hospitals Plans Digital Arm Stake Sale

Apollo Hospitals Enterprise Limited, Annual General Meeting, Aug 28, 2023

Full year 2023 earnings: EPS misses analyst expectations

Apollo Hospitals Enterprise Limited to Report Q4, 2023 Results on May 30, 2023

Upcoming dividend of ₹6.00 per share at 0.3% yield

Third quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Apollo Hospitals Enterprise Limited to Report Q3, 2023 Results on Feb 14, 2023

Second quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

First half 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Apollo Hospitals Enterprise Limited to Report Q2, 2023 Results on Nov 10, 2022

Apollo Hospitals Enterprise Limited (NSEI:APOLLOHOSP) agreed to acquire 60% stake in Kerala First Health Services Pvt. Ltd. for INR 263.7 million.

Upcoming dividend of ₹11.75 per share

Full year 2022 earnings: EPS exceeds analyst expectations

Apollo Hospitals Enterprise Limited to Report Q1, 2023 Results on Aug 11, 2022

Apollo Hospitals Enterprise Limited Recommends Dividend for the Financial Year Ended 31st March 2022, payable on or before 6th September 2022

MD & Executive Director recently bought ₹9.5m worth of stock

Adani, Apollo Reportedly Explore Bids for Majority Stake in Metropolis

Price target decreased to ₹4,972

Apollo Hospitals Enterprise Limited Recommends Dividend for the Financial Year Ended 31 March 2022

Amazon, Flipkart Reportedly in Talks to Buy Stake in Metropolis Healthcare

Apollo Hospitals Enterprise Limited (NSEI:APOLLOHOSP) acquired Junction Mall for INR 1.7 billion.

Third quarter 2022 earnings: EPS misses analyst expectations

Apollo Hospitals Enterprise Limited to Report Q3, 2022 Results on Feb 11, 2022

MD & Executive Director recently sold ₹3.6b worth of stock

Investor sentiment improved over the past week

Price target increased to ₹5,205

Second quarter 2022 earnings released: EPS ₹17.24 (vs ₹4.33 in 2Q 2021)

Investor sentiment improved over the past week

Price target increased to ₹4,259

Upcoming dividend of ₹3.00 per share

Full year 2021 earnings released: EPS ₹10.74 (vs ₹32.70 in FY 2020)

SoftBank Reportedly Eyes Stake in Apollo Hospitals’ Pharmacy Arm

Full year 2021 earnings released: EPS ₹10.74 (vs ₹32.70 in FY 2020)

Price target increased to ₹3,453

Non-Executive Independent Director has left the company

New 90-day high: ₹3,091

Price target raised to ₹2,764

Apollo Hospitals Enterprise Limited to Report Q3, 2021 Results on Feb 12, 2021

Apollo Hospitals Enterprise Limited has completed a Follow-on Equity Offering in the amount of INR 11.699999 billion.

New 90-day high: ₹2,687

New 90-day high: ₹2,509

New 90-day high: ₹2,283

Price target raised to ₹2,320

Second quarter 2021 earnings released: EPS ₹4.33

Revenue and earnings beat expectations

Apollo Hospitals Enterprise Limited (NSEI:APOLLOHOSP) signed a definitive agreement share purchase agreement to acquire remaining 50% stake in Apollo Gleneagles Hospital Limited from Gleneagles Development Pte Ltd for INR 4.1 billion.

Apollo Hospitals Enterprise Limited to Report Q2, 2021 Results on Nov 11, 2020

Price target raised to ₹2,051

New 90-day high: ₹2,173

Apollo Hospitals Enterprise Limited announced that it expects to receive $20 million in funding from International Finance Corporation

Price target raised to ₹1,845

New 90-day high: ₹1,829

First quarter earnings released

Upcoming Dividend of ₹2.75 Per Share

Full year earnings released - EPS ₹32.70